Skip to main content
Premium Trial:

Request an Annual Quote

Chip-Man Moves to New HQ, Starts Shipping Cell Analysis Tools in Europe for Evaluation

NEW YORK, July 29 (GenomeWeb News) - Chip-Man Technologies of Tampere, Finland, has moved into new facilities, the company said today.

 

The purpose-built, 270 square meter (2,900 square feet) facility will help the firm to "optimize our operations and also place us at the heart of the exciting new biomedical hub being formed in Tamperefor regenerative medicine," according to a company statement.

 

Chip-Man is now starting to release its Cell-IQ cell imaging system to various sites in Europefor evaluation. Cell-IQ monitors morphological and physiological changes in cell lines, primary cells, co-cultures, and monolayer tissue models in real time.

The Scan

Study Links Genetic Risk for ADHD With Alzheimer's Disease

A higher polygenic risk score for attention-deficit/hyperactivity disorder is also linked to cognitive decline and Alzheimer's disease, a new study in Molecular Psychiatry finds.

Study Offers Insights Into Role of Structural Variants in Cancer

A new study in Nature using cell lines shows that structural variants can enable oncogene activation.

Computer Model Uses Genetics, Health Data to Predict Mental Disorders

A new model in JAMA Psychiatry finds combining genetic and health record data can predict a mental disorder diagnosis before one is made clinically.

Study Tracks Off-Target Gene Edits Linked to Epigenetic Features

Using machine learning, researchers characterize in BMC Genomics the potential off-target effects of 19 computed or experimentally determined epigenetic features during CRISPR-Cas9 editing.